SCHEMBL6589095

SCHEMBL6589095

COc1cc2c(cc1OC)CN(C(=O)C1CCCN(CCNC(=O)c3ccc(F)c(F)c3)C1)CC2

nearest known ligand 0.52

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.50
MEN1 O00255 1/20 0.50
DRD3 P35462 5/20 0.47
SIGMAR1 Q99720 2/20 0.47
DRD2 P14416 2/20 0.47
DRD4 P21917 3/20 0.46
KDM4E B2RXH2 1/20 0.45
ATM Q13315 1/20 0.45
TDP1 Q9NUW8 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
KDM2B Q8NHM5 1/20 0.44
DRD1 P21728 1/20 0.44
MMP9 P14780 1/20 0.44
ABCB1 P08183 1/20 0.44
PDE4B Q07343 1/20 0.43
PDE4D Q08499 1/20 0.43
HCRTR1 O43613 1/20 0.43
HCRTR2 O43614 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29773210 0.93 DRD3 (0.55) KMT2AMEN1DRD3SIGMAR1DRD2
SCHEMBL3991767 0.93 DRD3 (0.55) KMT2AMEN1DRD3SIGMAR1DRD2
SCHEMBL3991771 0.93 DRD3 (0.55) KMT2AMEN1DRD3SIGMAR1DRD2
Hydrochloric Acid SCHEMBL6586295 0.91 KMT2A (0.54) KMT2AMEN1DRD3SIGMAR1DRD2
Phosphoric Acid SCHEMBL3996517 0.90 DRD3 (0.53) KMT2AMEN1DRD3SIGMAR1DRD2
Phosphoric Acid SCHEMBL3996528 0.90 DRD3 (0.53) KMT2AMEN1DRD3SIGMAR1DRD2
SCHEMBL6587232 0.89 SIGMAR1 (0.51) KMT2AMEN1DRD3SIGMAR1DRD2
SCHEMBL6587045 0.87 DRD4 (0.57) KMT2AMEN1DRD3DRD2DRD4
SCHEMBL6587983 0.86 KDM4E (0.53) KMT2AMEN1DRD3SIGMAR1DRD2
Hydrochloric Acid SCHEMBL6007678 0.86 KDM4E (0.53) KMT2AMEN1DRD3SIGMAR1DRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1186601-B1 NOVEL ISOQUINOLINE DERIVATIVES OR SALTS THEREOF YAMANOUCHI PHARMA CO LTD (JP) 2004-03-24 EP claimed
US-6573279-B1 Drug, particularly to a novel isoquinoline derivative or its salt having an If current inhibitory effect without serious side effects such as convulsion and also to a drug, particularly a cardiac rate lowering agent, containing the ASTELLAS PHARMA INC. (JP) 2003-06-03 US claimed
EP-1186601-A1 NOVEL ISOQUINOLINE DERIVATIVES OR SALTS THEREOF YAMANOUCHI PHARMACEUTICAL CO. LTD. (JP) 2002-03-13 EP claimed